AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 201 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $169,000 | +333.3% | 5,978 | +242.6% | 0.01% | +500.0% |
| Q2 2022 | $39,000 | -22.0% | 1,745 | +15.3% | 0.00% | -50.0% |
| Q4 2021 | $50,000 | +127.3% | 1,513 | +214.6% | 0.00% | +100.0% |
| Q3 2021 | $22,000 | -87.7% | 481 | -85.2% | 0.00% | -83.3% |
| Q2 2021 | $179,000 | +5.9% | 3,253 | -16.6% | 0.01% | -25.0% |
| Q4 2020 | $169,000 | -49.9% | 3,899 | -59.5% | 0.01% | -77.8% |
| Q3 2020 | $337,000 | +1103.6% | 9,636 | +1011.4% | 0.04% | +350.0% |
| Q3 2019 | $28,000 | +366.7% | 867 | +588.1% | 0.01% | +166.7% |
| Q4 2018 | $6,000 | -82.9% | 126 | -69.3% | 0.00% | -75.0% |
| Q2 2018 | $35,000 | -5.4% | 410 | -9.5% | 0.01% | -36.8% |
| Q1 2018 | $37,000 | +640.0% | 453 | +409.0% | 0.02% | +375.0% |
| Q4 2017 | $5,000 | -68.8% | 89 | -63.1% | 0.00% | -63.6% |
| Q3 2017 | $16,000 | -20.0% | 241 | -39.0% | 0.01% | -47.6% |
| Q2 2017 | $20,000 | +1900.0% | 395 | +1480.0% | 0.02% | +2000.0% |
| Q1 2017 | $1,000 | -99.3% | 25 | -99.1% | 0.00% | -98.7% |
| Q3 2016 | $143,000 | +1000.0% | 2,700 | +800.0% | 0.08% | +420.0% |
| Q2 2016 | $13,000 | +225.0% | 300 | +200.0% | 0.02% | +87.5% |
| Q1 2016 | $4,000 | – | 100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
| Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
| Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
| Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
| Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
| Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |